Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Schedule of Warrants

The following represents a summary of warrants for the three months ended March 31, 2023 and the year ended December 31, 2022:

	Three Months Ended March 31, 2023				Year Ended December 31, 2022
	Number		Weighted Average Exercise Price		Number		Weighted Average Exercise Price
Beginning balance	5,678,836		$	1.84	3,161,568		$	1.60
Granted	1,765,862		1.17		2,517,268		2.22
Ending balance	7,444,698		$	1.68	5,678,836		$	1.84
Warrants exercisable	7,444,698				5,678,836
Intrinsic value of warrants	$	1,242,174			$	1,374,303
Weighted Average Remaining Contractual Life (Years)	6.15				5.48

Schedule of Options

The following represents a summary of options for the three months ended March 31, 2023 and the year ended December 31, 2022:

	Number	Weighted Average Exercise Price		Weighted-Average Remaining Contractual Term (in Years)	Weighted Average Fair Value
Outstanding, December 31, 2022	6,425,000	$	2.69	5.63	$	4.26
Granted	812,500	1.62		6.84	1.10
Outstanding. March 31, 2023	7,237,500	$	2.57	5.55	$	3.91
As of March 31, 2023
Vested and exercisable	3,178,870	$	2.24	5.21	$	3.20

Schedule of Stock Options, Valuation Assumptions

The following assumptions were used for the periods as follows:

	Three Months Ended March 31, 2023	Year Ended December 31, 2022
Expected term	7 years	7 years
Expected volatility	116 – 162%	114 – 157%
Expected dividend yield	—	—
Risk-free interest rate	3.53 – 3.89%	2.00% - 4.18%